Stay informed with the latest litigation news. Explore now

IP Verse

Teva Pharmaceuticals International GmbH v. Almaject Inc. - 1:25-cv-01168

Explore the details of the Teva Pharmaceuticals International GmbH v. Almaject Inc. case under case number 1:25-cv-01168 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-01168
Filing Date
Sep 18, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Alvogen, Inc. -
Eagle Sub1 LLC -
Cephalon LLC -
Teva Pharmaceuticals International GmbH -
Almaject Inc. -

Patents Involved

This case involves 19 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11844783B2
-US9572797B2
-US9572796B2
-US9265831B2
-US12343333B2
-US12350257B2
-US9144568B2
-US9572887B2
-US9034908B2
-US9597397B2
-US10010533B2
-US9597398B2
-US9579384B2
-US8609707B2
-US9597399B2
-US12138248B2
-US11872214B2
-US10052385B2
-US9000021B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Sep 18, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than August 6, 2025. Date of Expiration of Patent: 8,609,707 expires 8/11/2031, 9,265,831 expires 1/28/2031, 9,572,796 expires 1/28/2031, 9,572,797 expires 1/28/2031, 9,034,908 expires 3/15/2033, 9,144,568 expires 3/15/2033, 9,572,887 expires 3/15/2033, 9,597,397 expires 3/15/2033, 9,597,398 expires 3/15/2033, 9,597,399 expires 3/15/2033, 9,000,021 expires 3/15/2033, 9,579,384 expires 3/15/2033, 10,010,533 expires 1/28/2031, 10,052,385 expires 3/15/2033, 11,844,783 expires 1/28/2031, 11,872,214 expires 1/28/2031, 12,138,248 expires 1/28/2031, 12,350,257 expires 1/28/2031, 12,343,333 expires 1/28/2031.Thirty Month Stay Deadline: 2/6/2028. (slk) (Entered: 09/19/2025)PACER Document
Sep 18, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk) (Entered: 09/19/2025)PACER Document
Sep 18, 2025COMPLAINT against Almaject Inc. & Alvogen, Inc. (Filing fee $ 405, receipt number ADEDC-4792848) - filed by Teva Pharmaceuticals International GmbH, Cephalon LLC, Eagle Pharmaceuticals, Inc., Eagle Sub1 LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Civil Cover Sheet)(slk) (Entered: 09/19/2025)PACER Document